FDA Inspection 834425 — McGuff Pharmaceuticals, Inc.

McGuff Pharmaceuticals, Inc. — FEI 2022073

The FDA completed an inspection of McGuff Pharmaceuticals, Inc. on May 31, 2013 in Santa Ana, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 31, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Santa Ana, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.